Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2019 Sep 3:8:e50148.
doi: 10.7554/eLife.50148.

What makes the hepatitis C virus evolve?

Thomas R O'Brien  1 , Rune Hartmann  2 , Ludmila Prokunina-Olsson  3
Affiliations
Comment

What makes the hepatitis C virus evolve?

Thomas R O'Brien et al. Elife. .

Abstract

Polymorphisms in the IFNL4 gene that affect both the presence and the form of the coded protein are associated with changes in the hepatitis C virus.

Keywords: Hepatitis C; genetics; genomics; host-pathogen interactions; human; infectious disease; innate immunity; interferon-lambda 4; microbiology; virus.

PubMed Disclaimer

Conflict of interest statement

TO TRO'B: Co-inventor (with LP-O) on a patent for the IFN-λ4 protein held by the National Cancer Institute. RH No competing interests declared, LP LP-O: Co-inventor (with TRO'B) on a patent for the IFN-λ4 protein held by the National Cancer Institute.

Comment on

References

    1. Ansari MA, Pedergnana V, Ip CL C, Magri A, Von Delft A, Bonsall D, Chaturvedi N, Bartha I, Smith D, Nicholson G, McVean G, Trebes A, Piazza P, Fellay J, Cooke G, Foster GR, STOP-HCV Consortium. Hudson E, McLauchlan J, Simmonds P, Bowden R, Klenerman P, Barnes E, Spencer CCA. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nature Genetics. 2017;49:666–673. doi: 10.1038/ng.3835. - DOI - PMC - PubMed
    1. Ansari MA, Aranday-Cortes E, Ip CLC, da Silva Filipe A, Hin LS, Bamford CGG, Bonsall D, Trebes A, Piazza P, Sreenu V, Cowton VM, STOP-HCV Consortium. Hudson E, Bowden R, Patel AH, Foster GR, Irving WL, Agarwal K, Thomson EC, Simmonds P, Klenerman P, Holmes C, Barnes E, Spencer CCA, McLauchlan J, Pedergnana V. Interferon lambda 4 impacts the genetic diversity of hepatitis C virus. eLife. 2019;8:e42463. doi: 10.7554/eLife.42463. - DOI - PMC - PubMed
    1. Chaturvedi N, Svarovskaia ES, Mo H, Osinusi AO. Adaptation of hepatitis C virus to interferon lambda polymorphism across multiple viral genotypes. eLife. 2019;8:e42542. doi: 10.7554/eLife.42542. - DOI - PMC - PubMed
    1. Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HL, Irving WL, Sheridan D, Abate ML, Adams LA, Mangia A, Weltman M, Bugianesi E, Spengler U, Shaker O, Fischer J, Mollison L, Cheng W, Powell E, Nattermann J, Riordan S, McLeod D, Armstrong NJ, Douglas MW, Liddle C, Booth DR, George J, Ahlenstiel G, International Hepatitis C Genetics Consortium (IHCGC) Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nature Communications. 2015;6:6422. doi: 10.1038/ncomms7422. - DOI - PMC - PubMed
    1. Kelemen LE, Lawrenson K, Tyrer J, Li Q, Lee JM, Seo JH, Phelan CM, Beesley J, Chen X, Spindler TJ, Aben KK, Anton-Culver H, Antonenkova N, Australian Cancer Study. Australian Ovarian Cancer Study Group. Ovarian Cancer Association Consortium Genome-wide significant risk associations for mucinous ovarian carcinoma. Nature Genetics. 2015;47:888–897. doi: 10.1038/ng.3336. - DOI - PMC - PubMed

Publication types